Product Information
CALCIUM CARB 1,250 MG/5 ML SUS is a generic product labeled by PAI Holdings LLC, priced at $0.0204 per ML under NDC 00121076616. Its NADAC has been published 602 times since Jan 22, 2014.
Strength
1250 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121076616
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CALCIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
12/1/2004
Pharmacological Classes
Price Statistics
The NADAC for CALCIUM CARB 1,250 MG/5 ML SUS has been published 602 times since Jan 22, 2014, and over the history we have for it it has risen 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0204 per ML |
|---|---|
| All-time high | $0.0205 (Jun 10, 2026) |
| All-time low | $0.0018 (May 22, 2019) |
| 52-week high | $0.0205 |
| 52-week low | $0.0201 |
| Median price | $0.0166 |
| Average price | $0.0168 |
| Largest weekly change | +796.1% (May 20, 2020) |
| Weeks tracked | 602 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Calcium Carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium Carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CALCIUM CARB 1,250 MG/5 ML SUS?
The current National Average Drug Acquisition Cost (NADAC) for CALCIUM CARB 1,250 MG/5 ML SUS, manufactured by PAI Holdings LLC, is $0.0204 per ML (NDC 00121076616), effective Sep 30, 2026.
How has the price of CALCIUM CARB 1,250 MG/5 ML SUS changed over time?
Over the history we have for it, the NADAC for CALCIUM CARB 1,250 MG/5 ML SUS has risen 25.9%. It has been tracked across 602 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CALCIUM CARB 1,250 MG/5 ML SUS?
Since Jan 22, 2014, the NADAC for CALCIUM CARB 1,250 MG/5 ML SUS has ranged from a low of $0.0018 (May 22, 2019) to a high of $0.0205 (Jun 10, 2026), with a median of $0.0166 per ML.
Are there cheaper alternatives to CALCIUM CARB 1,250 MG/5 ML SUS?
No other NADAC-published product currently shares the active ingredient and strength of CALCIUM CARB 1,250 MG/5 ML SUS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CALCIUM CARB 1,250 MG/5 ML SUS?
CALCIUM CARB 1,250 MG/5 ML SUS (NDC 00121076616) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.